BLACKROCK INNOV & GRW TRM TR (BIGZ)

US09260Q1085

7.5  -0.1 (-1.32%)

After market: 7.56 +0.06 (+0.8%)

Fundamental Rating

1

Taking everything into account, BIGZ scores 1 out of 10 in our fundamental rating. BIGZ was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BIGZ have multiple concerns. BIGZ has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

BIGZ had negative earnings in the past year.
In the past year BIGZ had a positive cash flow from operations.

1.2 Ratios

Industry RankSector Rank
ROA -73.47%
ROE -74.07%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BIGZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

BIGZ has less shares outstanding than it did 1 year ago.
There is no outstanding debt for BIGZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 55.13 indicates that BIGZ is not in any danger for bankruptcy at the moment.
BIGZ has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
BIGZ has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Even though the debt/equity ratio score it not favorable for BIGZ, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 55.13
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

BIGZ has a Current Ratio of 0.10. This is a bad value and indicates that BIGZ is not financially healthy enough and could expect problems in meeting its short term obligations.
BIGZ has a Quick Ratio of 0.10. This is a bad value and indicates that BIGZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1

0

3. Growth

3.1 Past

The earnings per share for BIGZ have decreased strongly by -168.03% in the last year.
Looking at the last year, BIGZ shows a very negative growth in Revenue. The Revenue has decreased by -60.25% in the last year.
EPS 1Y (TTM)-168.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.52%
Revenue 1Y (TTM)-60.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-78.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

BIGZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.55
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BIGZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLACKROCK INNOV & GRW TRM TR

NYSE:BIGZ (12/27/2024, 8:05:54 PM)

After market: 7.56 +0.06 (+0.8%)

7.5

-0.1 (-1.32%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners45.6%
Inst Owner Change0.58%
Ins OwnersN/A
Ins Owner Change0%
Market Cap0
Analysts0
Price TargetN/A
Short Float %0.06%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP-14.24%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-16 2024-12-16 (0.08676)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 490.75
P/FCF 5.55
P/OCF 5.55
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)-7.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.35
FCFY18.03%
OCF(TTM)1.35
OCFY18.03%
SpS0.02
BVpS9.74
TBVpS9.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -73.47%
ROE -74.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 8846.15%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z 55.13
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-168.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-60.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-78.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.69%
OCF growth 3YN/A
OCF growth 5YN/A